Search - tctmd.com

Displaying 821 - 840 of 972

Sort: Relevancy | Date

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Industry News

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

April 09, 2013

News Daily News

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Jason Kahn

March 25, 2013

News Daily News

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

March 25, 2013

News Conference News ACC 2013

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

Jason Kahn

March 11, 2013

News Daily News

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Yael L. Maxwell

March 09, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

February 25, 2013

News Industry News

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

January 27, 2013

News Industry News

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

January 07, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Daily News

SCAI Updates Recommendations for Ad Hoc PCI

Yael L. Maxwell

December 02, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Jason Kahn

November 06, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

News Industry News

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

October 25, 2012

Advertisement

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

CardioGuide System Enables Real-Time Navigation of Left Ventricular Leads During Medtronic CRT Implants

Study Looks at Adding Corticosteroid Treatment to Bare-Metal Stenting

Close FDA Panel Vote Favors MitraClip for MR Patients with No Other Options

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

Updated ‘STICH’ study concludes that Surgical Ventricular Reconstruction (SVR) in conjunction with CABG decreased mortality by 64% in heart failure patients compared with CABG

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

SCAI Updates Recommendations for Ad Hoc PCI

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

PARTNER: Benefits of TAVR Sustained Out to 3 Years

Experts Discuss Future of Renal Denervation

Clinical Trial Suggests PFO Closure with Investigational Device is Safe and May Improve Clinical Outcomes Compared to Medical Management in the Prevention of Cryptogenic Stroke

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content